Organic solvents as vehicles for precipitating liquid embolics: A comparative angiotoxicity study with superselective injections of swine rete mirabile

American Journal of Neuroradiology

Volumn 27, Issue 9, 2006, Pages 1900-1906

  Dudeck, Oliver ^a   Jordan, O ^b   Hoffmann, K T ^a   Okuducu, A F ^a   Tesmer, K ^a   Kreuzer Nagy, T ^a   Rufenacht D A ^c   Doelker, E ^b   Felix, R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRROLIDONE DERIVATIVE; 4 HYDROXYMETHYL 2,2 DIMETHYL 1,3 DIOXOLANE; DIMETHYL ISOSORBIDE; DIMETHYL SULFOXIDE; ETHYLENE VINYL ALCOHOL COPOLYMER; GLYCEROL DERIVATIVE; GLYCOFUROL 75; ISOSORBIDE DERIVATIVE; LACTIC ACID ETHYL ESTER; MACROGOL; N METHYLPYRROLIDONE; ONYX; ORGANIC SOLVENT; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY CATHETERIZATION; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ANGIOGRAPHY; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HEMOLYSIS; HISTOPATHOLOGY; NONHUMAN; SWINE; TOXICITY TESTING; VASOSPASM;

ALKENES; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANIMALS; BLOOD CIRCULATION; CEREBRAL ARTERIES; CHEMICAL PRECIPITATION; DIMETHYL SULFOXIDE; DRUG COMBINATIONS; EMBOLIZATION, THERAPEUTIC; ENDOTHELIUM, VASCULAR; FEMALE; GLYCEROL; HEMOLYSIS; ISOSORBIDE; LACTATES; MUSCLE, SMOOTH, VASCULAR; POLYETHYLENE GLYCOLS; PRECIPITATION; PYRROLIDINONES; SOLVENTS; SWINE;

EID: 33749680748     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Yang X, Wu Z, Li Y, et al. Re-evaluation of cellulose acetate polymer: angiographic findings and histological studies. Surg Neurol 2001;55:116-22
2. Mandai S, Kinugasa K, Ohmoto T. Direct thrombosis of aneurysms with cellulose acetate polymer. Part I: Results of thrombosis in experimental aneurysms. J Neurosurg 1992;77:497-500
3. Taki W, Yonekawa Y, Iwata H, et al. A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol 1990;11:163-68
4. Hamada J, Kai Y, Morioka M, et al. A mixture of ethylene vinyl alcohol copolymer and ethanol yielding a nonadhesive liquid embolie agent to treat cerebral arteriovenous malformations: initial clinical experience. J Neurosurg 2002;97: 881-88
5. Murayama Y, Vinuela F, Ulhoa A, et al. Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 1998;43:1164-75
6. Murayama Y, Vinuela F, Tateshima S, et al. Endovascular treatment of experimental aneurysms by use of a combination of liquid embolic agents and protective devices. AJNR Am J Neuroradiol 2000;21:1726-35
7. Jahan R, Murayama Y, Gobin YP, et al. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 2001;48:984-95
8. Mawad ME, Cekirge S, Ciceri E, et al. Endovascular treatment of giant and large intracranial aneurysms by using a combination of stent placement and liquid polymer injection. J Neurosurg 2002;96:474-82
9. Molyneux AJ, Cekirge S, Saatci I, et al. Cerebral Aneurysm Multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20 European centers. AJNR Am J Neuroradiol 2004;25:39-51
10. Nishi S, Taki W, Nakahara I, et al. Embolization of cerebral aneurysms with a liquid embolus, EVAL mixture: report of three cases. Acta Neurochir (Wien) 1996;138:294-300
11. Saatci I, Cekirge HS, Ciceri EF, et al. CT and MR imaging findings and their implications in the follow-up of patients with intracranial aneurysms treated with endosaccular occlusion with onyx. AJNR Am J Neuroradiol 2003;24: 567-78
12. Davis JM, Rowley SD, Braine HG, et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990;75:781-86
13. Samoszuk M, Reid ME, Toy PT. Intravenous dimethylsulfoxide therapy causes severe hemolysis mimicking a hemolytic transfusion reaction. Transfusion 1983;23:405
14. Stroncek DF, Fautsch SK, Lasky LC, et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:521-26
15. Smith DM, Weisenburger DD, Bierman P, et al. Acute renal failure associated with autologous bone marrow transplantation. Bone Marrow Transplant 1987; 2:195-201
16. Hameroff SR, Otto CW, Kanel J, et al. Acute cardiovascular effects of dimethyl sulfoxide. Ann N Y Acad Sci 1983;411:94-99
17. Rapoport AP, Rowe JM, Packman CH, et al. Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant 1991;7:401-03
18. Styler MJ, Topolsky DL, Crilley PA, et al. Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 1992; 10:435-38
19. Baum CM, Weissman IL, Tsukamoto AS, et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A 1992;89:2804-08
20. Burgess JL, Hamner AP, Robertson WO. Sulfhemoglobinemia after dermal application of DMSO. Vet Hum Toxkol 1998;40:87-89
21. Topacoglu H, Karcioglu O, Ozsarac M, et al. Massive intracranial hemorrhage associated with the ingestion of dimethyl sulfoxide. Vet Hum Toxicol 2004;46: 138-40
22. Chaloupka JC, Vinuela F, Vinters HV, et al. Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model. AJNR Am J Neuroradiol 1994;15:1107-15
23. Laurent A, Wassef M, Zhang HQ, et al. Solutions gélifiantes pour embolisation: etude animale de la toxicité cardiovasculaire d'un constituant, le diméthylsulfoxyde. J Neuroradiol 1997;24:314
24. Sampei K, Hashimoto N, Kazekawa K, et al. Histological changes in brain tissue and vasculature after intracarotid infusion of organic solvents in rats. Neuroradiology 1996;38:291-94
25. Hamada J, Kai Y, Morioka M, et al. A nonadhesive liquid embolic agent composed of ethylene vinyl alcohol copolymer and ethanol mixture for the treatment of cerebral arteriovenous malformations: experimental study. J Neueosurg 2002;97:889-95
26. Laurent A, Dufaux J, Honiger J, et al. Injectable gel-giving solutions for embolization: hydrodynamic and animal studies. Proceedings of the Société Française de Neuroradiologie (SFNR) 1997;25:46
27. Chaloupka JC, Huddle DC, Alderman J, et al. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR Am J Neuroradiol 1999;20:401-10
28. Mottu F, Laurent A, Rufenacht DA, et al. Organic solvents for pharmaceutical parenterals and embolic liquids: a review of toxicity data. PDA J Pharm Sci Technol 2000;54:456-69
29. Mottu F, Gailloud P, Massuelle D, et al. In vitro assessment of new embolic liquids prepared from preformed polymers and water-miscible solvents for aneurysm treatment. Biomaterials 2000;21:803-11
30. Powell MF, Nguyen T, Baloian L. Compendium of excipients for parenteral formulations. PDA J Pharm Sci Technol 1998;52:238-311
31. Heintz C, Boymond C. Aspects pharmaco-toxicologiques et utilisation thérapeutique de quelques solvants injectables non aqueux miscibles à l'eau. STP Pharma 1989;5:548-60
32. Mottu F, Stelling MJ, Rufenacht DA, et al. Comparative hemolytic activity of undiluted organic water-miscible solvents for intravenous and intra-arterial injection. PDA J Pharm Sci Technol 2001;55:16-23
33. National Industrial Chemicals Notification and Assessment Scheme. Canberra, Australia, 2004. Full report on Arlasolve DMI. Available at: http://www.nicnas. gov.au/publications/CAR/new/Std/stdFULLR/std1000FR/std1052FR. pdf. Accessed 2004 Oct 17
34. Simonsen L, Petersen MB, Groth L. In vivo skin penetration of salicylic compounds in hairless rats. Eur J Pharm Sci 2002;17:95-104
35. Squillante E, Needham T, Maniar A, et al. Codiffusion of propylene glycol and dimethyl isosorbide in hairless mouse skin. Eur J Pharm Biopharm 1998;46: 265-71
36. Arlasolve (Dimethyl isosorbide). ICI Technical Note, 1995
37. Hodosh M, Hodosh SH, Hodosh AJ. Treatment of aphthous stomatitis with saturated potassium nitrate/dimethyl isosorbide. Quintessence Int 2004;35: 137-41
38. Hazardous Substances Data Bank. Bethesda, MD: National Library of Medicine (US), 2004. Dimethyl isosorbide. Available at http://toxnet.nlm.nih. gov/cgi-bin/sis/htmlgen?HSDB. Accessed 2004 Oct 17
39. Report on carcinogens, 10th ed. Triangle Park, NC: US Department of Health and Human Services, Public Health Service, National Toxicology Program; 2002
40. Hazardous Substances Data Bank. Bethesda, MD: National Library of Medicine (US), 2004. 1-Methyl-2-pyrollidone. Available at http://toxnet.nlm.nih. gov/cgi-bin/sis/htmlgen?HSDB. Accessed 2004 Oct 17
41. Priborsky I, Muhlbachova E. Evaluation of in-vitro percutaneous absorption across human skin and in animal models. J Pharm Pharmacol 1990;42:468 -72
42. Koizumi A, Fujii M, Kondoh M, et al. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biopharm 2004;57:473-78
43. 14C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: in vivo and in vitro percutaneous absorption. Drug Metab Dispos 2003;31:659-69
44. Akesson B, Paulsson K. Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine. Occup Environ Med 1997;54:236-40
45. Akesson B, Jonsson BA. Major metabolic pathway for N-methyl-2-pyrrolidone in humans. Drug Metab Dispos 1997;25:267-69
46. Pharmasolve (N-methyl-2-pyrrolidone). ISP Technical Note, 1990
47. Wells DA, Thomas HF, Digenis GA. Mutagenicity and cytotoxicity of N-methyl-2-pyrrolidinone and 4-(methylamino)butanoic acid in the Salmonella/microsome assay. J Appl Toxicol 1988;8:135-39
48. Engelhardt G, Fleig H. 1-Methyl-2-pyrrolidinone (NMP) does not induce structural and numerical chromosomal aberrations in vivo. Mutat Res 1993; 298:149-55
49. Zimmermann FK, Holzwarth UL, Scheel I, et al. Aprotic polar solvents that affect porcine brain tubulin aggregation in vitro induce aneuploidy in yeast cells growing allow temperatures. Mutat Res 1988;201:431-42
50. Mayer VW, Goin CJ, Taylor-Mayer RE. Aneuploidy induction in saccharomyces cerevisiae by two solvent compounds, 1-methyl-2-pyrrolidinone and 2-pyrrolidinone. Environ Mol Mutagen 1988;11:31-40
51. Lee KP, Chromey NC, Culik R, et al. Toxicity of N-methyl-2-pyrrolidone (NMP): teratogenic, subchronic, and two-year inhalation studies. Fundam Appl Toxicol 1987;9:222-35
52. Saillenfait AM, Gallissot F, Langonne I, et al. Developmental toxicity of N-methyl-2-pyrrolidone administered orally to rats. Food Chem Toxicol 2002; 40:1705-12
53. Saillenfait AM, Gallissot F, Morel G. Developmental toxicity of N-methyl-2-pyrrolidone in rats following inhalation exposure. Food Chem Toxicol 2003;41: 583-88
54. Reed KW, Yalkowsky SH. Lysis of human red blood cells in the presence of various cosolvents. J Parenteral Sci Technol 1985;39:64-68